A night of celebration, legacy, and community spirit marked a historic milestone for AGBU Manoogian-Demirdjian School as nearly 900 guests gathered for its 50th Anniversary Gala, raising over an ...

Education Foundation announced the recipients of its 2026 scholarships, honoring four post-acute care nursing professionals who are advancing their education to strengthen clinical leadership and ...

Today, the American Association of Post-Acute Care Nursing (AAPACN®) announced the recipients of its 2026 AAPACN Awards for Post-Acute Care Professionals, honoring the individuals and organizations ...

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, ...

The initiative offers student loan repayment to nursing & therapy graduates and to current employees, including ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

A father is appealing for donors as his teenage son faces a life-threatening blood disorder and needs a stem cell transplant within weeks to improve his chances of survival.

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Nursing home operators, as always, are juggling many moving parts to stay ahead, but some initiatives are taking precedence this year – particularly ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and rema ...